SC-26196
SIGMA/PZ0176 - ≥98% (HPLC)
Synonym: SC-26196; a,a-
Empirical Formula (Hill Notation): C27H29N5
Molecular Weight: 423.55
MDL Number: MFCD11226148
Linear Formula: C27H29N5
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to tan |
form | powder |
InChI | 1S/C27H29N5/c28-23-27(25- |
InChI key | QFYKXKMYVYOUNJ-JBASAIQMSA |
manufacturer/tradename | Pfizer® |
originator | Pfizer |
Quality Level | 100 |
SMILES string | N#CC(CCCN1CCN(CC1)N=Cc2 |
solubility | DMSO: ≥10 mg/mL |
storage temp. | 2-8°C |
Application: | SC-26196 has been used as an inhibitor of delta6 (Δ6) fatty acid desaturase: • in mouse inner medullary collecting duct (IMCD3) and human (female) embryonic kidney (HEK) 293 cell culture as Dulbecco′s modified eagle′s medium (DMEM) component • in hepatic HepG2 cells • in glioblastoma cell lines to test its effect post-radiation treatments |
Biochem/physiol Actions: | SC-26196 is a Delta6 fatty acid desaturase (Delta6D) inhibitor. It specifically inhibited Delta6D activity with an IC(50) value of 100 nM. The rate-limiting step in arachidonic acid synthesis is the desaturation of dietary linoleic acid by Delta6D. SC-26196 completely prevented this conversion of linoleic acid to arachidonic acid. |
Legal Information: | Pfizer is a registered trademark of Pfizer, Inc. |
Legal Information: | Sold for research purposes under agreement from Pfizer Inc. |
Other Notes: | This compound was developed by Pfizer for Lipid Signaling research . To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |